Novo Nordisk Inc. is a major pharmaceutical company that makes drugs, including treatments for diabetes and obesity. It lobbies Congress on health issues like medication affordability and access, coverage for obesity drugs, and diabetes prevention programs; it also works on patent and copyright matters, Medicare and Medicaid policy, budget and appropriations, and corporate and international tax rules. The company has reported hiring Williams & Jensen and spending about $240,000 across filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHRISTOPHER E. WILCOX
The latest disclosures for this client.
WILLIAMS AND JENSEN, PLLC
Q3WILLIAMS AND JENSEN, PLLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
WILLIAMS AND JENSEN, PLLC
JEANNE HAGGERTY
WILLIAMS AND JENSEN, PLLC
mr CHRISTOPHER W HATCHER
WILLIAMS AND JENSEN, PLLC
mr MATTHEW B HOEKSTRA
WILLIAMS AND JENSEN, PLLC
ms MELINDA M MAXFIELD
WILLIAMS AND JENSEN, PLLC
SUSAN HIRSCHMANN
WILLIAMS AND JENSEN, PLLC
ROBERT BUTORA
WILLIAMS AND JENSEN, PLLC
KURT SCHRADER
WILLIAMS AND JENSEN, PLLC
WILLIAMS AND JENSEN, PLLC
Q1WILLIAMS AND JENSEN, PLLC
Q4WILLIAMS AND JENSEN, PLLC
Q3WILLIAMS AND JENSEN, PLLC
Q2WILLIAMS AND JENSEN, PLLC
Q1